Compounds for inhibiting NLRP3 and uses thereof
US11319319B1 · kind B1 · utility
11Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2021 |
| Grant date | May 3, 2022 |
| Priority date | — |
| Expiry date | Nov 17, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to inhibitors of NLRP3 useful in the treatment of diseases and disorders inhibited by said protein and having the Formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.